In the ever-evolving world of biopharma and medical research, experts like Ivan Kairatov are at the frontier of innovation. With profound expertise in technology and development within the sector, Ivan sheds light on a groundbreaking development that could redefine how we understand aging. The
Artificial intelligence (AI) is making significant strides in the healthcare sector, reshaping how diseases are detected and providing new tools for health education, especially for adolescents. As the incidence of Lyme disease rises and the thirst for health information among young people grows,
Emerging at the intersection of biotechnology and artificial intelligence, Absci is positioning itself as a transformative entity in the drug discovery landscape. This strategic positioning comes as the company recently announced a significant $50 million capital raise, a maneuver that underscores
Artificial Intelligence (AI) is significantly transforming the healthcare industry, altering how care is delivered, experienced, and managed. As medical institutions worldwide strive for more effective and efficient service delivery, AI emerges as a pivotal force driving innovation and
The promise of artificial intelligence (AI) in enhancing medical research is becoming increasingly apparent, as recent advancements have brought significant changes to genetic studies related to Alzheimer’s disease. Alzheimer's is a debilitating condition that progressively erodes memory and
Over 35% of responses from language models regarding addiction questions contain stigmatizing language. This startling statistic highlights a significant issue in AI-driven communication within healthcare. How might such biases, which reflect broader societal prejudices, impact patient trust and
